About Spero Oncology
Spero Oncology is a company based in Bellshill (United Kingdom) founded in 2014 was acquired by Veristat in May 2016.. Spero Oncology operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.
- Headquarter Bellshill, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Spero Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spero Oncology
Spero Oncology has secured backing from 1 investor. Prominent investors backing the company include Veristat. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical trials and regulatory submissions are supported as a CRO.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spero Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spero Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spero Oncology Comparisons
Competitors of Spero Oncology
Spero Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| domain | founded_year | HQ Location |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| domain | founded_year | HQ Location |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| domain | founded_year | HQ Location |
CRO offering clinical development services for oncology drugs
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical oncology drug development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Spero Oncology
When was Spero Oncology founded?
Spero Oncology was founded in 2014.
Where is Spero Oncology located?
Spero Oncology is headquartered in Bellshill, United Kingdom. It is registered at Bellshill, Scotland, United Kingdom.
What does Spero Oncology do?
Spero Oncology was established in 2014 in Bellshill, United Kingdom, as a contract research organization focused on the oncology sector. Clinical operations support is delivered for oncology trials, encompassing feasibility studies, legal representation in the European Union, clinical monitoring, project management, protocol writing, and regulatory strategy. Services are extended primarily across Europe, Australia, and New Zealand. The organization was acquired by U.S.-based CRO Veristat for an undisclosed amount.
Who are the top competitors of Spero Oncology?
Who are Spero Oncology's investors?
Spero Oncology has 1 investor. Key investors include Veristat.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.